These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 31713950)

  • 21. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
    Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
    Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical significance of the region between Helix 1 and 2 for efficient dominant-negative inhibition by conversion-incompetent prion protein.
    Taguchi Y; Mistica AM; Kitamoto T; Schätzl HM
    PLoS Pathog; 2013; 9(6):e1003466. PubMed ID: 23825952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Semisynthesis of membrane-attached prion proteins.
    Chu NK; Becker CF
    Methods Enzymol; 2009; 462():177-93. PubMed ID: 19632475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying critical sites of PrP(c)-PrP(Sc) interaction in prion-infected cells by dominant-negative inhibition.
    Taguchi Y; Schätzl HM
    Prion; 2013; 7(6):452-6. PubMed ID: 24401595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurometals in the Pathogenesis of Prion Diseases.
    Kawahara M; Kato-Negishi M; Tanaka KI
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discriminating between cellular and misfolded prion protein by using affinity to 9-aminoacridine compounds.
    Phuan PW; Zorn JA; Safar J; Giles K; Prusiner SB; Cohen FE; May BCH
    J Gen Virol; 2007 Apr; 88(Pt 4):1392-1401. PubMed ID: 17374787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of the in vivo folding of the prion protein. A bipartite function of helix 1 in folding and aggregation.
    Winklhofer KF; Heske J; Heller U; Reintjes A; Muranyi W; Moarefi I; Tatzelt J
    J Biol Chem; 2003 Apr; 278(17):14961-70. PubMed ID: 12556465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prion protein functions and dysfunction in prion diseases.
    Sakudo A; Ikuta K
    Curr Med Chem; 2009; 16(3):380-9. PubMed ID: 19149584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A seven-residue deletion in PrP leads to generation of a spontaneous prion formed from C-terminal C1 fragment of PrP.
    Munoz-Montesino C; Larkem D; Barbereau C; Igel-Egalon A; Truchet S; Jacquet E; Nhiri N; Moudjou M; Sizun C; Rezaei H; Béringue V; Dron M
    J Biol Chem; 2020 Oct; 295(41):14025-14039. PubMed ID: 32788216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mechanisms of prion transmission].
    Sakaguchi S
    Nihon Rinsho; 2007 Aug; 65(8):1391-5. PubMed ID: 17695274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity and Architecture of Pathological Prion Protein Assemblies: Time to Revisit the Molecular Basis of the Prion Replication Process?
    Igel-Egalon A; Bohl J; Moudjou M; Herzog L; Reine F; Rezaei H; Béringue V
    Viruses; 2019 May; 11(5):. PubMed ID: 31083283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential solubility of prions is associated in manifold phenotypes.
    Kuczius T; Karch H; Groschup MH
    Mol Cell Neurosci; 2009 Nov; 42(3):226-33. PubMed ID: 19607920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered prion protein glycosylation in the aging mouse brain.
    Goh AX; Li C; Sy MS; Wong BS
    J Neurochem; 2007 Feb; 100(3):841-54. PubMed ID: 17144900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular biology and pathology of prion strains in sporadic human prion diseases.
    Gambetti P; Cali I; Notari S; Kong Q; Zou WQ; Surewicz WK
    Acta Neuropathol; 2011 Jan; 121(1):79-90. PubMed ID: 21058033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sheep scrapie susceptibility-linked polymorphisms do not modulate the initial binding of cellular to disease-associated prion protein prior to conversion.
    Rigter A; Bossers A
    J Gen Virol; 2005 Sep; 86(Pt 9):2627-2634. PubMed ID: 16099922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formation of native prions from minimal components in vitro.
    Deleault NR; Harris BT; Rees JR; Supattapone S
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9741-6. PubMed ID: 17535913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does the tail wag the dog? How the structure of a glycosylphosphatidylinositol anchor affects prion formation.
    Bate C; Nolan W; Williams A
    Prion; 2016 Mar; 10(2):127-30. PubMed ID: 26901126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation.
    Cordeiro Y; Machado F; Juliano L; Juliano MA; Brentani RR; Foguel D; Silva JL
    J Biol Chem; 2001 Dec; 276(52):49400-9. PubMed ID: 11604397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The octarepeat region of the prion protein is conformationally altered in PrP(Sc).
    Yam AY; Gao CM; Wang X; Wu P; Peretz D
    PLoS One; 2010 Feb; 5(2):e9316. PubMed ID: 20195363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.